Filing Details
- Accession Number:
- 0001127602-20-010524
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-13 09:05:05
- Reporting Period:
- 2020-03-12
- Accepted Time:
- 2020-03-13 09:05:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 794172 | Meridian Bioscience Inc | VIVO | In Vitro & In Vivo Diagnostic Substances (2835) | 310888197 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1719325 | P. John Kenny | 3471 River Hills Drive Cincinnati OH 45244 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-03-12 | 30,000 | $5.78 | 238,324 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Prices range from $5.7300 per share to $5.7900 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
Billionaire Hedge Funds
